Venture capital funding in life sciences – including biotechnology and medical device manufacturing – decreased 22 percent from the fourth quarter of 2011 in the first quarter of 2012, according to a PricewaterhouseCoopers report. Venture capitalists invested $1.5 billion during the that quarter. Deal volume was also down, dropping 11 percent during the same period. When […]
This content is only available to members of the CSBJ. To gain access, you'll need to sign in or purchase Digital, Silver Membership, Print & Digital, Print, Digital and The Transcript, Corporate Membership or Digital Monthly If you're already a member, sign in here.